Feasibility of circulating tumor DNA-based minimal residual disease (ctDNA-MRD)-guided adjuvant chemotherapy in patients with stage II-III gastric cancer (GC): An adaptive trial (MRD-GATE).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Lian Liu, Song Li, Hui Qu, Wenbin Yu, Xin Zhang, Pengyu Li, Xiaohan Cui, Meng Wei, Di Zhang, Mingchi Ma, Jin Hu, Chengjun Wang, Beian Xia
Institutions: Shandong University, Qilu Hospital of Shandong University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410816924